HRT decreases DNA and lipid oxidation in postmenopausal women

Climacteric

Volumn 16, Issue 1, 2012, Pages 104-110

  Escalante Gomez C ^a,b   Quesada Mora, S ^b  

^a HOSPITAL SAN JUAN DE DIOS   (Costa Rica)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Aging; Antioxidants; Atherosclerosis; Hormone Replacement Therapy; Oxidation

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 8 HYDROXYDEOXYGUANOSINE; CATALASE; CONJUGATED ESTROGEN; ESTRADIOL; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PROTEIN; PROTEIN CARBONYL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROTROPIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYSTERECTOMY; LIPID OXIDATION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84872475029     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.660711     Document Type: Article

References (52)

1. Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot (Lond) 2003;91: 179-94
2. Scandalios JG. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defensas. Braz J Med Res 2005;38: 995-1014 (Pubitemid 41078961)
3. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54: 176-86 (Pubitemid 32205036)
4. Halliwell B, Gutteridge JMC, eds. Antioxidant defenses. In Free Radicals in Biology and Medicine, 3rd edn. New York: Oxford University Press, 1998
5. Willcox J, Ash S, Catignani G. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44: 275-95 (Pubitemid 39301554)
6. Tribble DL, Frank E. Dietary antioxidants, cancer and atherosclerotic heart disease. West J Med 1994;161: 605-12
7. Ortiz A, Vargas R, Muñ oz G. Incidencia y mortalidad del cá ncer en Costa Rica. Costa Rica: Kamelot Comunicaci ó n y Arte, 2005
8. Stocker R, Keaney J. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84: 1381-478 (Pubitemid 39302636)
9. Heinecke J. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141: 1-15 (Pubitemid 28539412)
10. Salonen T, Yla-Herttulal S, Yamamoto R. Autoantibodies against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339: 883-7
11. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. ACJN 1991;53: 326-34S
12. Stampfer MJ, Hennekens CH, Manson J, Colditz G, Rosner B, Willett W. Vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993;328: 1444-9 (Pubitemid 23143846)
13. Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6 (Pubitemid 26091640)
14. Yusuf S. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 2000;354: 1917-18 (Pubitemid 30419061)
15. Ebell MH. Efficacy of antioxidants in GI cancer prevention. Am Fam Physician 2005;71: 465-6 (Pubitemid 40194064)
16. Salaganik RL. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001;20(Suppl): 464-75S
17. Lamson DW, Brignall MS. Antioxidants and cancer. 3. Quercetin. Altern Med Rev 2000;5: 304-29
18. Christen Y. Oxidative stress in Alzheimer' s disease. A m J Clin Nutr 2000;71: 621-9S
19. Smith MA, Perry G, Richery PL. Oxidative damage in Alzheimer's disease. Nature 1996;382: 120-1
20. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age related cataract and vision loss: AREDS report no.9. Arch Ophthalmol 2001; 119: 1439-52
21. Ehret A, Westendorp MO, Herr I, et al. Resistance of chimpanzee T cells to human virus type 1 Tat-enhanced oxidative stress and apoptosis. J Virol 1996;70: 6502-7 (Pubitemid 26266882)
22. Strehlow K, Rotter S, Wassmann S, et al. Modulation of antioxidant lipid expression and function by estrogen. Circ Res 2003; 93: 170-7 (Pubitemid 36919705)
23. Unfer T, Conterato M, da Silva J, Duarte M, Emanuelli T. Influence of hormonal replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chem Acta 2006;369: 73-7 (Pubitemid 43783393)
24. Signorelli S, Neri S, Sciacchitano S, DiPino L, Costa M, Marchese G. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006;53: 77-82 (Pubitemid 41736062)
25. Lippert TH, Seeger H, Mueck A. Clinical and pharmacological characteristics of the conjugated equine estrogens. Is their use in postmenopausal hormone replacement therapy still up to date? Arnzneimitteltherapie 1999;17: 362-4
26. O ' Connell MB. Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol 1995;35 (Suppl): 18-24S
27. Bhavanani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med 1998;217: 6-16
28. Lippert TH, Seeger H, Mueck A. Pharmocodynamics and toxicology of different estrogens. Hormone replacement in postmenopausal women: are all estrogens equal? Gynecol Endocrinol 2001;15: 26-33
29. Ayres S, Abplanalp W, Liu J, Ravi T. Mechanisms involved in the protective effect of estradiol-17 on lipid peroxidation and DNA damage. Am J Physiol 199;274:E1002-8
30. Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77: 1095-7 (Pubitemid 23301492)
31. Taniguchi S, Yanase T, Kobayashi K, et al. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2-) catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins. Endocr J 1994;41: 605-11
32. Ke R, Todd D, Ahokas R. Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil Steril 2003;79: 1118-22 (Pubitemid 36547848)
33. Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocinol 2004;19: 57-63 (Pubitemid 39331405)
34. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 1987;213: 9-14 (Pubitemid 17036123)
35. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Molec Biol 1998;108: 101-6
36. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366: 43-58
37. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991;266: 2005-8 (Pubitemid 21909019)
38. Kampa M, Nistikaki A, Tsaousis V. A new automated method for the determination of the total antioxidant capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol 2002;2: 3-18
39. Beckman KB, Arnes B. Oxidative decay of DNA. J Biol Chem 1997;272: 19633-6 (Pubitemid 27340047)
40. Espeland M, Hogan P, Fineberg S, et al. Effects of postmenopausal therapy on glucose and insulin concentration. Diabetes Care 1998;21: 189-95
41. Kanaya A, Herrington D, Vittinghoff E, et al. Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2003;138: 1-9
42. Liu S, Le May C, Wong MP, et al. Importance of extranuclear estrogen receptor and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009;58: 22902-302
43. Friday K, Dong C, Fontenot R. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2001;86: 48-52 (Pubitemid 32109774)
44. Lamon-Fava S, Herrington DM, Horvath KV, Schaefer EJ, Asztalos BF. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism 2010;59: 1794-800
45. Lamon-Fava S, Herrington DM, Reboussin DM, et al. Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis 2009;205: 325-30
46. Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer E. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and highdensity lipoproteins. Metabolism 2003;52: 1330-6 (Pubitemid 37351102)
47. Arteaga E, Rojas A, Villaseca P, Bianchi M, Arteaga A, Duran D. In vitro effect of estradiol, progesterone, testosterone and of combined estradiol/progestins on low density lipoprotein oxidation in postmenopausal women. Menopause 1998;5: 16-23 (Pubitemid 28257382)
48. Ozden S, Dildar K, Hakan Y, Guilzar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 2001;38: 165-70 (Pubitemid 32295930)
49. Wen Y, Doyle M, Norris L, et al. Combined oestrogenprogesterone replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol 1999;47: 315-21 (Pubitemid 29131347)
50. Naziroglu M, Simsek M, Simsek H, Aydilek N, Ozcan Z, Artilgan R. The effects of hormone replacement therapy combined with vitamins C and E on antioxidant levels and lipid profiles in postmenopausal women with type 2 diabetes. Clin Chim Acta 2004;344: 63-71 (Pubitemid 38626138)
51. Wassmann K, Wassmann S, Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 2005;97: 1046-54 (Pubitemid 41668918)
52. Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005;36: 172-6 (Pubitemid 41657528)